Introduction
Impulsivity is implicated in virtually all substance-related and addictive disorders and many other forms of psychopathology, which has caused an explosion of research in this area over the last two decades. This research has revealed that the construct is highly multidimensional and complex in its measurement, despite having robust and repeatable predictive validity. However, the translation of this knowledge to clinical practice has been strikingly slow. The novelty of this review relative to previous reviews on this topic is the integration of multiple complementary models of addiction in which impulsivity and its different dimensions and measurement modalities figure prominently. Furthermore, this review will attempt to demonstrate empirical evidence in support of the link between the multidimensional structure of impulsivity and its neurocognitive correlates with contemporary views on the structure of psychopathology and risk for different types of substance use disorders (SUDs). Finally, this multidimensional, integrative framework will serve to highlight promising intervention strategies for the treatment and prevention of addictive behaviours focusing on management of dimensions of impulsivity.
Impulsivity in the twenty-first century
The term impulsivity has existed in human language for more than five centuries and has been recognized as playing a key role in psychiatric conditions since the & 2018 The Author(s) Published by the Royal Society. All rights reserved.
birth of the fields of neurology and psychiatry [1] . Impulsivity is defined by the International Society for Research on Impulsivity as ' behaviour without adequate thought, the tendency to act with less forethought than do most individuals of equal ability and knowledge, or a predisposition toward rapid, unplanned reactions to internal or external stimuli without regard to the negative consequences of these reactions'. Impulse control has become recognized as a crucial survival skill and enhancing impulse control is viewed as a key societal goal for the twenty-first century, as for the first time in human history we live in a society where food is readily available, addictive substances and technology are easily accessible, and immediate gratification is the modus operandi of popular culture. As eloquently argued by Terry Moffitt, impulse control is more necessary now than ever before in human history in order to prevent addiction, stay healthy, resist spending, and save for retirement [2] .
Impulsivity and drug addiction
With regards to SUDs in particular, impulsivity has been shown to be both an antecedent risk factor considered a vulnerability marker for SUDs [3] and a consequence of chronic substance use associated with structural and functional neurobiological changes [4] . The definition of impulsivity maps closely to current conceptualizations of addiction, considered to be a chronic relapsing brain disease characterized by 'uncontrollable, compulsive drug craving, seeking and use, even in the face of negative health and social consequences' [5] . Indeed, contemporary theories of addiction [6 -10] conceptualize the disorder primarily as a syndrome of impaired impulse control, proposed to be the core mechanism underlying the compulsive pattern of drug seeking and use, which, in combination with individual differences in other neurobiological domains such as compulsivity or negative emotionality, are crucial to understanding the heterogeneity of addictive disorders [9, 11] .
Despite the notable advances in the study of impulsivity in addictive disorders, the lack of clinical translation of these advances has been striking. One source of variability in linking impulsivity to addiction vulnerability is the attempt by researchers to study the role of impulsivity in single disorders, by statistically covarying other forms of psychopathology, or other forms of substance use. This artificial simulation of unitary conditions is not supported by research on the structure of psychopathology (e.g. [12, 13] ), where impulsivity also appears to be a central common vulnerability to many externalizing conditions [12] , and potentially all psychiatric conditions [13, 14] . What is lacking in the literature is an integrative model that incorporates a multimodal approach to the measurement of impulsivity and its different dimensions, which attempts to explore their specificity with respect to different types of addictions and co-occurring mental disorders.
Impulsivity versus impulsivities: integrative multimodal framework
Trait dimensions of impulsivity are measured with self-report instruments that are based on self-evaluation of how people view themselves relative to others. In contrast, state dimensions are measured by performance on neurocognitive tasks tapping much more narrowly defined cognitive and affective processes, in which individuals are generally required to choose between short-term and long-term gains and losses, or to inhibit a response to a pre-potent urge, a valued reward, or a delay cue [16] [17] [18] . While it is recognized that such measures can also be used to identify trait-level individual differences [19] , they have the potential to tap more within-person variability. In this respect, self-report measures could reveal who is at general risk, whereas neurocognitive measures, may more accurately predict who is at immediate risk [16] . Combining the two approaches may lead to better identification of individuals who are at particularly high risk and increase our understanding of the relationship between multiple putative addiction phenotypes, which may help redefine them as multi-level combination of traits and states [20] that could be targeted by tailored personality and neurocognitive interventions.
(a) Trait impulsivity-personality dimensions
Most models of personality propose that behaviour is governed by at least two independent systems, considered to be heritable biological traits. One is associated with avoidance behaviour, broadly reflecting the personality trait of anxiety, and the other with approach behaviour, reflecting impulsivity [21] . Eysenck and his biologically-based trait theory of personality [22] inspired other similar omnibus theories, such as those of Cloninger [23] and Zuckerman [24] , which incorporate variously named constructs related to impulsivity (e.g. impulsiveness, venturesomeness, novelty seeking, sensation seeking) and emphasize their importance in relation to specific subtypes of substance abuse. Barratt and colleagues [25, 26] propose a more multifaceted conceptualization of trait impulsivity, delineating attentional, motor, and non-planning sub-components. Similarly, others [27 -29] have used the Five Factor Model of Personality [30] to emphasize the hierarchical and context-dependent nature of self-report impulsivity, identifying five lower-order trait impulsivity facets: (lack of ) premeditation, (lack of ) perseverance, sensation seeking, negative urgency (tendency to act impulsively under negative affect), and positive urgency (tendency to act impulsively under positive affect). Valiant attempts have been made to impose structure across these various trait measures to come to some agreement on the true nature of trait impulsivity and its dimensions, with hierarchical factor analyses agreeing on at least two broad dissociable trait dimensions that account for a significant portion of the variance across most self-report impulsivity measures: Impulsiveness (Unprepared/Spontaneous) and Sensation Seeking (in [31] ). Importantly, these traits were shown to be hierarchically organized and their common variance captured by a higher-order Impulsivity construct. Within this hierarchical structure, each domain was shown to subdivide into two additional lower order facets: Impulsiveness into traits of preparedness and spontaneous; and Sensation Seeking into thrill and adventure seeking and impatient pleasure seeking. As noted by Woicik et al. [32] , many personality scales were developed when impulsivity was considered a unitary construct and therefore fail to fully differentiate between these facets. Sensation Seeking [24] has items that tap impulsiveness and thrill and adventure seeking, despite its name, which causes further confusion in the field. In figure 1 , we attempt to provide some clarification of how the most widely used impulsivity scales map onto four empirically derived subfacets of impulsivity, as suggested in [31] . Another widely used multidimensional scale, the UPPS/UPPS-P [27] measures three dissociable traits, despite its numerous subscales, Negative/Positive Urgency, (lack of) Premeditation/perseverance, and Sensation Seeking, as revealed in meta-analysis of studies investigating the discriminative validity of this scale [27] . Self-report measures of trait impulsivity tend to have high predictive value with respect to substance use and misuse, psychopathology and other health risk behaviours [2, 33, 34] . Numerous studies using these personality scales have found a consistent relationship between measures of impulsivity, sensation seeking and drug addiction [35] [36] [37] [38] [39] [40] . Importantly, evidence from prospective studies indicates that impulsivity measured as a childhood temperament is linked to the later development of SUDs [41, 42] . Research indicates that trait impulsivity is a drug-vulnerability phenotype that exists prior to the development of SUDs, which is also elevated in biological siblings of chronic drug users, supporting its role as a behavioural endophenotype for SUDs [43] .
Increasingly, research has noted the need to consider specific facets of trait impulsivity when exploring different substance misuse profiles, defined along clinical, substance-related, and motivational dimensions [44, 45] . The emotion-based (negative and positive urgency), conscientiousness-based (lack of premeditation and lack of perseverance), and sensation seeking-based facets have been associated with different patterns of substance misuse that likely reflect different aetiological mechanisms with differential implications for treatment [38, 46] . Some facets, such as sensation seeking, appear to be more adaptive because despite their associations with early onset and heavy drinking [13, 33, 34, 47] , individuals scoring high on this trait show greater ability to maintain some control over drug intake and have fewer co-occurring symptoms of psychopathology [12, 38, 48] . In contrast, Impulsiveness (Unprepared/Spontaneous) is associated with problem drug and alcohol use (in [45] ), with some studies suggesting that the link between this facet of impulsivity and SUD is indirect and mediated through general tendency towards rule breaking and misconduct (e.g. [49] ). Whereas the majority of the evidence supporting the personality model of addiction vulnerability is based on alcohol, recent studies provide evidence for the role of facets of trait impulsivity as prospective risk factors for heavy alcohol and cannabis misuse [50, 51] and for sensation seeking as a risk factor for early initiation of both alcohol and cannabis use [51] . Impulsivity and sensation seeking are increasingly being recognized as separate [52, 53] , genetically distinct constructs [54] implicated in risk for substance misuse. Dissociating between them when considering the role of impulsivity in substance-related behaviours may increase their diagnostic and prognostic utility.
Despite a widely accepted notion of personality traits reflecting lasting and consistent individual differences, there is unequivocal evidence that personality traits tend to change across the lifespan [55] , with some traits (e.g. conscientiousness, extraversion) being more stable than others (e.g. neuroticism) [56] . For the most part, the measurement of personality traits involves central tendency variables, is often limited to a single assessment, and rarely involves methods that capture within-person variability. Figure 1 . Schemata for linking different impulsivity measures and facets to patterns of substance use and comorbid psychopathology through latent constructs of impulsivity and psychopathology. Self report trait measures in dark green, neurocognitive and computational parameters in lighter green, latent neurocognitive impulsivity constructs in orange, latent hierarchical psychopathology dimensions in light blue and observed DSM disorder in dark blue. Thick dark blue arrows from internalising symptoms and externalising symptoms reflect indirect relationship between latent psychopathology construct and specific substance use outcomes through externalizing and externalizing symptoms. P factor represents variance common to all psychiatric symptoms. Adapted from Castellanos-Ryan et al. [12] and Conrod & Nikolaou [11] .
(b) State impulsivity-neurocognitive dimensions
Although impulsivity is often thought of as a personality trait or predisposition, many of its contemporary conceptualizations involve distinct performance-based neurobehavioural manifestations, reflecting individual differences in valuation and decision-making that could be more sensitive to fluctuating momentary lapses in impulse control, influenced by environmental context and the current state of the individual. Neurocognitive manifestations of impulsivity fall into two broad domains, dissociable at both neuroanatomical and neuropharmacological levels [21, 52] . The first is 'impulsive action' [57] , also known as motor impulsivity, involving response inhibition [1, 58] and manifested as difficulty inhibiting or stopping prepotent or ongoing responses. Common tasks of impulsive action include stop signal tasks [59, 60] , which require cancellation of an already initiated response [61] , and go/no-go type of tasks [62] [63] [64] , which require inhibition of prepotent responses to external or internal signals. The second neurocognitive domain is 'impulsive choice' [65] , also known as cognitive impulsivity or reward-based impulsivity, which refers to the compromised ability to make decisions in line with long-term goals. It is related to: (i) sensitivity of choices to delay and preference for 'smaller-sooner over larger-later' rewards, measured with delay discounting paradigms [66] ; and (ii) sensitivity of choices to risk and reward, measured with reward-based decision-making tasks such as the Iowa Gambling Task [67] or the Cambridge Gambling Task [68] , or with risk-taking tasks such as the Balloon Analogue Risk Task [69] . These neurocognitive distinctions do show specificity with respect to relationships to facets of self-report impulsivity when investigated in a multivariate framework: Impulsiveness correlates with measures of response inhibition (action impulsivity), sensation seeking correlates with reward sensitivity measures on learning and passive avoidance tasks, and self-report measures of impatient pleasure seeking (a sub-facet of sensation seeking) most robustly correlate with delay discounting [31] .
Neuroimaging and neuropsychological studies assessing the relationship between facets of impulsivity and risk for SUDs suggest that self-report and neurocognitive measures of impulsivity are implicated as both causes and consequences of early onset substance misuse [4] . Castellanos-Ryan et al. [34] demonstrated that neurocognitive measures of reward sensitivity and action impulsivity independently mediated the longitudinal relationships between self-report sensation seeking and impulsiveness respectively, and adolescence substance misuse. Whelan et al. [70] showed that stopping behaviour, a form of impulsive action involving action cancellation, and its correlated neural network involving the inferior frontal gyrus, was implicated specifically in frequency of drug use, whereas other networks involved in stopping behaviour were related to drug use vulnerability, but not to frequency or severity of use. More recently, Morin et al. [71] analysed data from a longitudinal study of 4000 adolescents who were assessed annually on a number of impulsivity and executive cognitive functions over the course of adolescence (from 12 to 17 years). This analysis showed that neurocognitive measures of working memory and response inhibition (impulsive action) were associated with vulnerability to substance use in adolescence, but multi-level modelling of within-person variability on these neurocognitive measures also showed that onset and frequency of substance use, particularly cannabis use, were associated with, and longitudinally predicted, further changes in working memory and response inhibition (impulsive action), suggesting action inhibition is both causal and consequential to substance misuse.
A more recent analysis examining the role of different measures of impulsivity in adolescent substance use behaviours using this same longitudinal cohort and multi-level framework tested the independent contribution of selfreport trait impulsivity and errors of commission on a go/ no-go task (impulsive action) on adolescent drinking, binge drinking and drug use [72] . When age-related changes in impulsivity were modelled over a 4 year period at the between-and within-person level, both self-report and neurocognitive measures significantly contributed to the prediction of vulnerability to drug-related behaviours. However, between-group differences (mean level over the 4 year period) on both on self-report trait measures and on response inhibition/impulsive action measures were related to riskier patterns of alcohol and drug use, whereas within-person changes in trait impulsivity were related to within-person variability in frequency of alcohol consumption. Two machine-learning analyses involving large longitudinal cohorts of European [73] , Canadian and Australian [74] adolescents further confirm the independent and predictive role of trait impulsivity and sensation seeking in risk for alcohol misuse, and suggest that neurocognitive measures of impulsivity do not add to model prediction of 'who' is at risk when self-report traits are included. However, consistent with [72] there is emerging evidence that more complex predictive models that account for the multi-level and variable nature of impulsivities and substance use and that involve multimodal measures of impulsivity might prove to be additionally useful in determining when risk is most likely to be expressed, rather than who is at risk. This notion is being further investigated using more complex computational models of task-based neurocognitive measures.
(c) State impulsivity-computational dimensions
Neurocognitive tasks of impulsivity are often deliberately designed to be complex, in order to be ecologically valid and capture important aspects of real-life decision-making. Although this increases their ecological validity, it also leads to significant heterogeneity and implies that neurocognitive performance is an interaction and synthesis of several different underlying motivational, learning, and choice processes [75] . Therefore, failure to perform well on such tasks may have many different causes. For example, poor performance on the Iowa Gambling Task [76] of impulsive action, arguably the most commonly used decision-making task in the addiction literature, may be due to increased sensitivity to reward, to decreased sensitivity to loss, to poor learning and retention of task contingencies, or to an erratic and inconsistent response style. Computational models of such complex tasks break down performance into underlying components and use the parameters associated with these components to understand the mechanisms of the neurocognitive deficits displayed by different clinical populations [77, 78] .
Computational ideas permeate many areas of science, but have had surprisingly little impact on the way psychiatric disorders are phenotyped [79] . Recently, there has been an increased interest in the utility of computational modelling as a novel phenotyping tool in psychiatry and a novel paradigm for understanding psychopathology [80, 81] . Computational modelling has proven valuable for uncovering important differences in neurocognitive decision processes in various clinical populations [78] . Notably, computational parameters have been shown to be more sensitive to substance-specific and disorder-specific neurocognitive deficits than standard neurobehavioural performance indices [82] [83] [84] . For example, computational parameters robustly discriminate between opiate and stimulant users in protracted abstinence even within the context of no group differences in neurobehavioural performance [83] . Moreover, dynamic changes in specific computational parameters of decision-making, such as ambiguity tolerance, have been shown to predict imminent relapse in abstinent opioid-dependent individuals, who were followed up for the first seven months of treatment and retested up to 15 times with a decision-making/impulsive choice task [85] . This suggests that computational parameters may have not only diagnostic, but also prognostic utility when used in repeated measures designs, which can inform not only with whom to intervene, but also when to intervene. Overall, computational parameters can serve as novel prognostic and diagnostic state-dependent markers of addiction that can be used to track the trajectory of various neurocognitive dimensions of impulsivity and their associations with critical risk behaviours across different stages of the addiction cycle. There is an unexplored potential of using computational approaches to refine neurocognitive phenotyping of addictions, identify neurocognitive mediators of response to treatment, and increase the precision of treatment interventions for addictions. While between-group differences in self-report impulsivity and sensation seeking are robustly predictive of risk for substance use (e.g. [74] ) and hold promise as diagnostic markers, new research designs incorporating within-subject repeated measures, using multilevel modelling or ecological momentary assessment along with neurocognitive and computational modelling of measures of impulsive action and impulsive choice will help to better understand when an individual is more likely to take up use or relapse back to problematic use.
Dimensions of impulsivity and risk for psychopathology
Impulsivity is proposed to be a prime transdiagnostic marker for a wide range of psychiatric disorders [80, 86] and is one of the most frequent diagnostic criteria in the new edition of the Diagnostic and statistical manual of mental disorders (DSM-5; [87] ). It figures most prominently in externalizing spectrum disorders, such as attention deficit hyperactivity disorder (ADHD), conduct disorder, and antisocial personality disorder (ASPD), which are commonly comorbid with SUDs [18] . A common characteristic of these disorders is that they originate in childhood, have a pervasive pattern, and are frequently lifelong. Developmentally, there is a strong association between such disorders and subsequent drug use [88, 89] . Personality disorders in particular, such as ASPD, are thought of as trait-like dysfunctional patterns in cognitive, affective, interpersonal, and impulsivity domains [90] and are highly comorbid with SUDs [91] , which has led some to question whether antisocial behaviours should be viewed as independent of SUDs [92] . A potentially more informative alternative to the somewhat over-inclusive diagnosis of ASPD is psychopathy [93] , an extreme variant of ASPD, consisting of a constellation of affective, interpersonal and behavioural characteristics. Theories of psychopathy distinguish between primary (callous/unemotional) and secondary (antisocial/ impulsive) subtypes [94] , both of which share common traits such as hostility and aggression. However, primary psychopaths are characterized by grandiosity, superficiality, lack of empathy and remorse, and low to moderate levels of anxiety, whereas secondary types are more impulsive, anxious, with high levels of negative affectivity and emotional disturbances [95, 96] . Trait impulsivity has been shown to be the best predictor of both psychopathy and conduct disorder/ASPD [33, 97] . Psychopathy, particularly secondary psychopathy, is associated with SUDs [95, [98] [99] [100] but tends to be more strongly related to illicit drug use than to alcohol use [100] .
Research reveals differential relationships between externalizing disorders and neurocognitive dimensions of impulsive choice and impulsive action. ADHD has been associated more strongly with motor/action impulsivity [101, 102] , evidenced by studies with children and adults with ADHD, which indicate that the disorder is related more strongly to performance-based deficits on simpler tasks of impulsive action that involve response inhibition [101] , than on tasks of impulsive choice that involve reward and punishment contingencies (reviewed in [102] ). In contrast, studies with individuals with psychopathic traits indicate that psychopathy is primarily related to performance-based deficits on more complex tasks of impulsive choice involving various reward and punishment contingencies or delays [103] [104] [105] [106] [107] .
A number of theorists have suggested that SUDs and externalizing disorders represent common syndromes of disinhibition [108, 109] . The phenotypic association between trait impulsivity and externalizing disorders has been traced to common aetiological factors between these phenotypes [109] , which share a common genetic basis [54] , which suggests that impulsivity could be the common underlying mechanism linking externalizing disorders and SUDs. Longitudinal studies that have attempted to study the intra-individual coevolution of these two sets of problems suggest that substance misuse tends to be secondary to the onset of conduct problems in impulsive adolescents [33, 34, 49, 110] . By contrast, other dimensions of externalizing personality, such as sensation seeking, have been shown to be more directly linked to early onset alcohol misuse, with conduct problems arising after the onset of binge drinking [110] .
Recognizing that impulsivity and its facets exist along a continuum in the general population, the IMAGEN Research Consortium designed a longitudinal study to assess the role of different facets of impulsivity and reward-related behaviours in the emergence of psychopathological symptoms in a large sample of European adolescents (n ¼ 2200). Among the numerous studies from this consortium, three studies directly test how facets of impulsivity are implicated in different psychiatric outcomes [12, 13, 70] . Importantly, these studies first represented psychiatric symptoms and their comorbidity by deriving transdiagnostic latent dimensions (represented in figure 1 ) using structural equation modelling, which confirmed results from other similar studies on the structure of psychopathology [14] . The IMAGEN studies then showed that self-report, neurocognitive and functional neuroimaging measures of impulsivity and its facets naturally dissociated along these dimensions of psychopathology: variance common to all externalizing symptoms (including substance use) was related to self-report impulsivity and delay discounting. Variance specific to ADHD and Conduct Disorder symptoms was related to behavioural and functional brain imaging measures of stopping behaviour on go/no-go tasks of motor/action impulsivity, and variance specific to early onset alcohol misuse was specifically related to trait thrill seeking (SURPS-SS) and brain functional activity during reward anticipation [12, 13] . This study demonstrated that neurocognitive and functional neuroimaging measures provide additional specificity with respect to dissociating latent dimensions of psychopathology that could not be fully dissociated using self-report measures. In line with the emerging evidence reviewed in figure 1 , we place neurocognitive facets as intermediary variables between self-report measures and latent dimensions of psychopathology to demonstrate where diagnostic specificity might be achieved.
Impulsivities and substance-specific addiction vulnerabilities
Mounting evidence from the voluminous research on impulsivity over the past 20 years reveals that the multidimensional conceptualization of impulsivity is relevant to prediction and diagnosis of important addiction profiles that differ not only on patterns of comorbid psychopathology, but also with respect to specific class of substance of abuse. Numerous studies show that in addition to general liability to SUDs, substance-specific liability accounts for a significant portion of the variance in substance-related behaviours and problems [12, 13, 111] . Merikangas and colleagues [112] reveal substantial drug specificity in the type of drugs abused by individuals with dependence on a range of illicit drugs and the type of drugs abused by their relatives, with opiates exhibiting the highest degree of specificity relative to cocaine, cannabis, and alcohol. Similarly, there are key differences between different classes of drugs with regards to common versus drug-specific genetic variance, indicating that, despite evidence for shared vulnerability factor that underlies the misuse of marijuana, sedatives, stimulants, heroin/opiates, and psychedelics, there are marked differences in the extent to which different classes of drugs are influenced by shared vulnerability [113] . For instance, heroin has larger genetic influences unique to itself than any other drug, whereas most of the genetic influences on marijuana, stimulants, and sedative abuse are shared across drugs. Shared and specific environmental influences likely cause further dissociation in patterns of drug use.
When investigating the substance-specificity of different dimensions of impulsivity, it would be important to control for the general liability towards substance use (and potentially the role of impulsivity in that overall liability), and examine whether specific dimensions of impulsivity predict more specific behaviours and drug preferences. After accounting for the general drug use vulnerability, personality traits can predict which substances an individual is most likely to use more regularly or problematically in the context of polysubstance use. Analyses on adult substance users, heavy substance using college students, and high school students all indicate that self-report measures of trait impulsivity and sensation seeking discriminate between substance users who are prone to stimulant versus alcohol misuse, respectively [32, 33, 38, 114] . Trait impulsiveness has been associated with deficits in response inhibition/impulsive action, which predict a pattern of substance misuse that co-occurs with other externalizing symptoms more generally, and with conduct disorder symptoms specifically [34] . In contrast, trait sensation seeking has been associated with reward response bias/impulsive choice, which uniquely predicted binge drinking [34] . Interestingly, these two facets of trait impulsivity also predict self-report motives for substance use that map onto these different neurocognitive patterns: sensation seeking youth reported using alcohol for enhancement reasons, while impulsive youth reported a motivationally-undefined pattern of use and drinking, but were particularly at risk of misusing stimulants [32] . These findings on different self-report drinking motives have been replicated in college students and in adult inpatient polysubstance users [38, 115] .
Similarly, a recent study with a community sample of mono-dependent opiate and stimulant users who were in protracted abstinence revealed that only externalizing traits such as impulsivity and sensation seeking discriminate between substance-dependent individuals and non-dependent controls, whereas internalizing traits such as hopelessness and anxiety sensitivity do not [116] . Another study investigating the role of personality traits in differentiating patterns of substance misuse showed that among opioid-dependent individuals receiving opioid substitution therapy, self-report personality factors predicted who is likely to report illicit drug misuse during such treatment and what type of substance they are likely to misuse: sensation seeking predicted cannabis use, hopelessness predicted prescription opioid misuse, anxiety sensitivity predicted prescription sedative misuse and impulsivity predicted injection drug use [117] . According to the framework presented in figure 1 , some studies suggest that opioid dependence is predicted by the callous/unemotional factor of psychopathy (psychopathy 2) and internalizing traits such as depression and anxiety [38, 118] , whereas stimulant dependence is predicted by externalizing traits, particularly impulsiveness [32] and disinhibited/impatient sensation seeking [118] , which, according to [31] , likely reflects delay discounting/impatient sensation seeking.
With regards to neurocognitive measures of impulsivity, some neurocognitive deficits are associated with a general tendency towards substance misuse [68] . Indeed, reliable impairments have been documented on both impulsive choice [66, 107, [119] [120] [121] [122] and impulsive action tasks [123] [124] [125] [126] [127] [128] across a number of different drug classes. Yet, because specific drugs of abuse also differentially affect specific cognitive and motivational brain systems, many have hypothesized that specific neurocognitive profiles should be linked to misuse of specific classes of substances of abuse with distinct pharmacological properties [11] , for which there is empirical support from animal studies (e.g. [129, 130] ). Studies that have accounted for overall patterns of substance use and then examined the relationship between specific facets of impulsivity and specific patterns of substance use demonstrate substance-specific relationships [32, 117, 131] , reflected in figure 1 , with all substances of abuse loading on a general P factor (strongly related to delay discounting [31] ) and then personality-specific neurocognitively-mediated trajectories that are either primarily associated with specific substance use or secondarily associated through other psychopathological symptoms (thick blue arrows).
Research designs that have attempted to more closely examine this question have used adolescent cohort designs to observe the role of personality in predicting drug-specific patterns of use before the onset of substance dependence. Such studies similarly show that trait impulsivity but not trait sensation seeking predict stimulant prescription drug misuse, while other more internalizing traits predict misuse of prescription drugs with more sedative and analgesic properties [32, 49] , secondarily through psychiatric symptoms.
Using a functional neuroimaging approach to the study of impulsivity and its multifaceted nature, Whelan and colleagues [70] used data from the IMAGEN cohort of 2200 14-year-olds to link facets of action impulsivity, represented by distinct brain activation patterns during stopping, failed inhibition, and response to feedback, to different drug use patterns. General resilience to drug use was related to greater activation patterns in bilateral frontal regions during stopping, while frequent polysubstance use was associated with greater activity in the supplementary motor area and reduced activity in a right frontal region during stopping. Using this same dataset, Castellanos-Ryan et al. [13] examined the extent to which different substance use profiles were concurrently and longitudinally predicted by these same functional activity patterns during the stop task along with functional activity patterns on a reward anticipation task of reward sensitivity and a number of relevant neurocognitive measures. Cortical and subcortical brain activity patterns during stopping behaviour predicted general susceptibility to drug use and other externalizing psychopathology, whereas activity patterns during reward anticipation predicted substance-specific behaviours, particularly alcohol-related behaviours. Delay discounting related to general substance use vulnerability, whereas reduced prefrontal cortical activity during failed stopping behaviour and errors of commission on a go/no-go task of impulsive action predicted conduct problems and ADHD. Other multi-site studies involving brain and behavioural measures during neurocognitive tasks of impulsivity suggest not only that impulsivity dimensions predict future risk for substance misuse, but also that early onset substance misuse further impacts the development of these neurocognitive domains during adolescence and that there might be important substance-specific effects on certain neurocognitive functions [71, 74] .
A recent multi-site study investigated this question in adults at the level of brain structure by mega-pooling structural neuroimaging studies comparing participants with current dependence on at least one of five substances (alcohol, nicotine, cocaine, methamphetamine, or cannabis) to age-, sex-and sitematched controls [132] . This study revealed lower volume or thickness across many brain regions in substance-dependent individuals relative to non-dependent participants. Some of these differences were general and affected by all substances, whereas others were substance-specific. Structures related to substance dependence in general, regardless of drug class, included the insula and the medial orbitofrontal cortex, associated with disadvantageous choices on reward-based decision-making tasks of impulsive choice [76] . Alcohol was associated with the most pervasive, yet specific effects, which were particularly robust in subcortical regions, such as the hippocampus, amygdala, and nucleus accumbens, a region centrally implicated in reward processing. Surprisingly, nicotine, cannabis, and methamphetamine dependence did not have any substance-specific relationships to brain volume, but that is not to say that other imaging modalities such as task-based functional MRI might not be more sensitive to subtle functional differences that are not detectable at a structural level. Notably, opioid dependence was not investigated, which is in line with a general trend in the literature that has provided considerably less research attention to opioid addiction relative to other drugs [133] .
A few more recent studies have begun to compare the neurobehavioural performance of stimulant users with that of opiate users on performance-based measures of impulsive choice and impulsive action. Results generally indicate that stimulant users show higher neurocognitive impulsivity than opiate users [66, 68, 122, [134] [135] [136] . However, virtually all of these studies have been based on polysubstance users, which significantly complicates the study of drug-specific effects and represents one of the most formidable methodological challenges for the study of the unique effects of different classes of drugs in humans. Polysubstance use may explain some key inconsistencies between clinical and preclinical studies on addiction, as the majority of clinical studies are based on polysubstance using patterns, whereas the preclinical literature is largely based on single drug administration.
An interesting research design that helps elucidate the unique effects of specific classes of drugs while circumventing the problem of polysubstance use in human studies involves comparisons between unique populations of 'pure' substance users who are mono-dependent on different classes of drugs (e.g. [83, 106, 107, 118, [137] [138] [139] ). Such studies have revealed that mono-dependent heroin and amphetamine users display opposite relationships between trait and neurocognitive dimensions of impulsivity. Specifically, in amphetamine users high composite score on trait impulsivity (derived by factor analysis and likely reflecting the higher-order construct) was associated with poor response inhibition (motor/action impulsivity), whereas in heroin users high trait impulsivity was associated with intact response inhibition [137] . Further, a computational modelling study of impulsive choice in 'pure' heroin and amphetamine users using the Iowa Gambling Task revealed that decision-making deficits in opiate and stimulant users are driven by different underlying mechanisms, namely by reduced loss aversion in opiate users versus increased reward sensitivity in stimulant users [83] . A more recent study [118] used machine-learning approaches to examine the predictive utility of 54 personality, psychiatric, and neurocognitive indices of impulsivity and related constructs to differentiate heroin and amphetamine dependence. The study identified distinct substance-specific multivariate risk profiles that classified heroin and amphetamine dependence in new samples with high degree of accuracy (heroin AUC (area under the receiveroperating characteristic (ROC) curve) 0.87, amphetamine AUC 0.74). Amphetamine dependence was (uniquely) predicted by higher impulsive sensation seeking (disinhibition and excitement seeking) and higher hostility, whereas heroin dependence was uniquely predicted by lower sensation seeking, lower trait motor impulsivity, higher negative urgency, higher callous/unemotional levels of psychopathy, and higher depression and trait anxiety. From the neurocognitive measures of impulsivity, higher delay discounting and longer decision-making deliberation time predicted amphetamine dependence. In contrast, heroin dependence was predicted by higher delay aversion, lower risk-taking, and impaired decision-making on choice impulsivity tasks. Out of 54 predictors, the antisocial/impulsive facet of psychopathy was the only common predictor of both heroin and amphetamine dependence. A parallel study [140] used a similar machinelearning approach to predict current cocaine dependence and found analogous findings, which classified out-of-sample cocaine dependence with even higher degree of accuracy (AUC 0.91). These findings suggest that quick, economical, and easy to administer behavioural measures of impulsivity can serve as objective behavioural markers of distinct addiction risk profiles, which may facilitate the development of reliable and cost-effective risk assessment batteries and targeted interventions.
Recognizing the highly heritable nature of addiction vulnerability, many studies have investigated the extent to which personality and neurocognitive dimensions of impulsivity might represent putative endophenotypes for addiction. From the multiple neurocognitive dimensions of impulsivity, delay discounting has received the strongest support as a candidate endophenotype for SUDs [120, 141] , though it is also a candidate marker for a number of externalizing disorders [80, 120] and general psychopathology [12] . The first genome-wide association study (GWAS) of delay discounting [142] revealed that the most significant association was with a gene implicated in the internalization of the serotonin transporter. Recent GWAS studies of trait impulsivity and sensation seeking [54, 143] revealed that these traits are genetically distinct, which further supports their conceptual separation. These findings are consistent with twin and sibling-pairs design studies reporting evidence for potential substance-specificity of different trait and state markers. For example, trait impulsiveness (measured with the Barratt Impulsiveness Scale-11 [26] ) appears to be a putative endophenotype for stimulant dependence, as indicated by significant correlations between sibling-pairs of stimulant-dependent individuals and their biological non-dependent siblings [43, 144] . In contrast, sensation seeking (measured with the Sensation Seeking Scale-Form V [24] ) was specific for sibling-pairs discordant for heroin dependence [144] . ADHD [145] and anxiety sensitivity [146] were specific to sibling-pairs discordant for amphetamine dependence, whereas hopelessness (measured with the Substance Use Risk Profile Scale [32] ) was specific to sibling-pairs discordant for heroin dependence [144] , suggesting that these traits are specifically implicated as endophenotypes, and not consequences, of drug use. Finally, neurocognitive indices of impulsive choice were common to both opiate and stimulant sibpairs (general risk), whereas an index of impulsive action, go/no-go commission errors, was specific to amphetamine sibling-pairs (substance-specific risk linked to ADHD) [144] . These substance-specific phenotypic associations suggest that certain endophenotypic markers may be common across addictions, whereas others may be specific to risk for dependence on specific classes of drugs.
Impulsivities as novel diagnostic and prognostic tools for addictions
One of the key problems in addictive disorders is their aetiological and functional heterogeneity, which is not well captured by the current psychiatric nosology, despite revolutionary advances in understanding the neurobiology of addiction. Integrating neuroscience and computationallybased assessments with self-report trait assessments may transform the diagnosis and classification of addictive disorders and lead to better targeted and more effective prevention and intervention approaches. To address the futility of DSM criteria to address the heterogeneity of DSM diagnostic categories, the US National Institute of Mental Health (NIMH) launched the Research Domain Criteria (RDoC) [147] as an attempt to determine if a novel way of classifying mental illness based on neurobiology, observable behaviour, and context will be useful for diagnosing mental disorders. The recently proposed heuristic framework for neuroclinical assessment of addictions (Addictions Neuroclinical Assessment, ANA) [9] is a modified version of the RDoC criteria adapted specifically for the assessment of addictions. The ANA framework posits that in order to better understand the different aetiological mechanisms implicated in various forms of addictions, their assessment should be multidimensional and combine clinical, personality, neurocognitive, neuroimaging and genetic approaches that focus on three key neurofunctional domains associated with impulsivity and compulsivity: executive function, incentive salience, and negative emotionality. Another recent conceptual framework that derived from the European context focuses on variance that is unique to SUDs (chronic and elevated patterns of consumption) in an attempt to steer clear of psychopathological constructs and potentially stigmatizing terms when addressing harm from substances, but recommends a similar framework when referring to risk for SUDs [148] . Nevertheless, there is a consensus across neuropsychiatric conceptualizations of addition (e.g. [149] ), all of which recommend more refined approaches to phenotyping, to accurately and efficiently capture the hierarchical and multidimensional nature of addiction vulnerability, particularly around brain processes linked to impulsivity, compulsivity, and positive and negative emotionality [9, 149] . Consistent with other reviews, we recommend incorporating self-report trait measures, as well as neurocognitive state measures that include both the standard neurobehavioural performance indices as well as computational indices that hold promise as novel phenotyping tools. Unlike these other reviews, we also suggest that such a multidimensional framework will further inform patterns of comorbidity and specific patterns of substance misuse vulnerability. Despite its complexity relative to the very simple task of assessing severity of substance use (e.g. the World Health Organisation's Alcohol Use Disorder Identification Test [150] ), assessment time and burden could be reduced significantly through adaptive design optimization [75, 151] , which may facilitate the development of 'smart' assessment batteries, composed of brief, targeted, and accurate multivariate assessment modules that may improve the precision around underlying motivational processes driving the behaviour and personalized treatment options.
Within this context, motor/action impulsivity and cognitive/choice impulsivity, best captured by a combination of self-report, neurocognitive, and computational measures, seem to provide important discriminant and predictive validity with respect to predicting or explaining dissociable substance misuse and concurrent psychiatric symptom dimensions. Measures of motor/action impulsivity appear to be useful in differentiating between individuals who might be prone to a primary disorder of ADHD and Conduct Disorder (including ASPD) as well as stimulant dependence, whereas differential responses to reward-based impulsive choice tasks might help identify individuals who are differentially susceptible to alcohol (risk sensitivity), or opiate dependence (loss insensitivity). Other reviews focus more attention on the progression of addiction and the impact of substances of abuse on these brain processes (see [149] ). This distinction might further explain why reward sensitivity is not predictive of risk for stimulant drug use but seems to characterize stimulant drug users with a history of dependence (e.g. [83, 118, 140] ).
Conceptualizing individuals prone to high levels of comorbidity across substance use and psychiatric disorders as having transdiagnostic impairments on specific trait or state dimensions of impulsivity might save clinicians time in pursuing diagnostic specificity, which often delays treatment and contributes to the revolving door between addiction and mental health services for such patients. One important outstanding question is whether treatment planning in accordance with this framework will lead to better outcomes for individuals with SUDs. New evidence indicates this is a promising approach.
Impulsivities: novel behavioural targets for prevention and treatment of substance use disorders
Researchers in the field have begun to address the question about the extent to which different dimensions of impulsivity are modifiable by various psychosocial, pharmacological and neurocognitive interventions. A number of psychosocial interventions could now be considered helpful tools in the management of impulsivity. For example, contingency management is used to reduce delay discounting around abstinence, cognitive-behavioural interventions are used to help patients better manage positive and negative urgency states in high-risk situations (e.g. relapse prevention), and mindfulness-based approaches are hypothesized to reduce negative urgency by reducing stress and rebalancing fronto-striatal connectivity [152] . However, few interventions directly arise from current research on impulsivity and even fewer targeted interventions have been shown to reduce impulsivity [153] . One such personality-targeted cognitive-behavioural approach involves modifying traditional cognitive-behaviour therapy (CBT) strategies to target individual differences in trait impulsivity. This programme, known as the Preventure Programme (see [154] ), uses the CBT framework to help high-risk youth understand how individual differences in trait impulsivity and response inhibition affect behavioural and emotional control and decision making. Cognitivebehavioural interventions are adapted to help impulsive youth become better 'stoppers' by helping them to identify high-risk situations and the interoceptive cues that precede an impulsive action. They are also given cognitive strategies to help them be more cognizant of the 'stopping' process and the cognitive processes required for better stopping (e.g. attentiveness, self-talk, goal-orientation). When delivered to adolescents with elevated scores on self-report measures of impulsiveness, measured with the Substance Use Risk Profile Scale (SURPS) [32] , the intervention is shown to produce long-term changes in theoretically predicted ways: substance use onset is delayed [114, 155] , conduct symptoms are reduced and/or prevented [156] , and reductions in self-report levels of impulsivity specifically mediate long-term changes in these behaviours [157] . The Preventure Programme also includes a second intervention targeting sensation seeking by using a different set of cognitive strategies focused on managing reward sensitivity and reward-driven behaviours. This second intervention has been shown to produce robust effects on binge drinking [154] and cannabis use outcomes [51] , without having a significant impact on conduct problems, aggressive behaviours or impulsivity, suggesting some treatment specificity in personality-targeted CBT interventions. It remains to be determined if these interventions produce changes in neurocognitive measures of impulsivity, and whether these changes mediate long-term behavioural changes [11] .
Other novel therapeutic approaches target neurocognitive dimensions of impulsivity. Some of the most promising approaches in this area are based on behavioural economic principles and dual-system models of decision-making that involve executive and impulsive decision systems [158, 159] . Increased delay discounting reflects greater control of the impulsive over the executive decision system and characterizes reinforcement pathologies, such as SUDs [160] . Delay discounting has recently been considered a genetically-influenced target for drug abuse prevention [161] . Therapeutic approaches based on dual system models use computerized working memory training and episodic future thinking to modify delay discounting and expand the constricted temporal horizon characterizing the addictive state [162] . Such training has the strongest effects in substance-dependent individuals who display the steepest delay discounting [163] .
According to this review, such interventions hold promise for reducing risk for substance misuse and psychopathological symptoms generally. A number of other neurocognitive intervention strategies also show promise as adjunct treatment for addictions. For example, response inhibition and working memory training have been found to curb impulsive drinking in problem drinkers, particularly in individuals who score low on these functions [164] [165] [166] . Cognitive bias modification has also shown promise in the treatment of addictions and other forms of psychopathology [167] . Neurocognitive measures of impulsivity might be more suitable than trait measures for use in tracking treatment effects and outcomes, owing to their state-dependent nature. For example, excessive delay discounting predicts initiation of drug use, improves with treatment, and returns within the normal range with abstinence [141] .
Another promising intervention approach stemming from the neurocognitive understanding of impulsivity is the use of repetitive Transcranial Magnetic Stimulation (TMS), which is a non-invasive, and safe, human brain stimulation technology based on electromagnetic induction [168] used to depolarize brain neurons [169] . Repetitive high-frequency (5 Hz) TMS can modulate long-term cortical excitability, repetitive TMS (rTMS) at a low frequency (about 1 Hz) produces inhibitory effects on neurons. Systematic reviews suggest that excitatory rTMS produces distinct effects on different impulsivity subdomains: small-to-moderate effects on response inhibition/impulsive action and moderate effects on delay discounting/choice impulsivity [170] . Whether these effects translate to changes in substance use behaviour is less well investigated, but it has been suggested that rTMS might produce small reductions in some relevant addiction outcomes, such as impulsivity [151] and craving [171] . There is also evidence that combining the excitatory and inhibitory effects of rTMS in relation to different environmental stimuli (e.g. drug versus natural reward cues) can reverse the reward sensitivity resulting from neurophysiological changes from repeated drug exposure [172] . What has yet to be investigated is whether these effects are mediated by changes in impulsivity or subdomains of impulsivity as outlined in this review.
Finally, considering that some reviews suggest that metacognitive executive function training for externalizing problems is effective when combined with supervised coaching with parents [173] , more studies are needed in which modular combinations of neurocognitive and cognitivebehavioural interventions are evaluated and tested. There is an unexplored therapeutic potential of integrating personality with neurocognitive and other intervention modules, based on individual risk factors, which may optimize the precision and efficacy of targeted intervention approaches for addictions.
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